Abbott Laboratories (ABT) EBT Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.64% |
| Dec 31, 2025 | -0.25% |
| Sep 30, 2025 | 8.94% |
| Jun 30, 2025 | 32.52% |
| Mar 31, 2025 | 22.94% |
| Dec 31, 2024 | 42.05% |
| Sep 30, 2024 | 11.96% |
| Jun 30, 2024 | 7.84% |
| Mar 31, 2024 | 17.84% |
| Dec 31, 2023 | 13.64% |
| Sep 30, 2023 | 18.41% |
| Jun 30, 2023 | 16.06% |
| Mar 31, 2023 | 29.37% |
| Dec 31, 2022 | 18.12% |
| Sep 30, 2022 | 22.94% |
| Jun 30, 2022 | 51.47% |
| Mar 31, 2022 | 31.34% |
| Dec 31, 2021 | 21.61% |
| Sep 30, 2021 | 73.95% |
| Jun 30, 2021 | 13.52% |
| Mar 31, 2021 | 299.80% |
| Dec 31, 2020 | 125.45% |
| Sep 30, 2020 | 14.76% |
| Jun 30, 2020 | -11.81% |
| Mar 31, 2020 | -0.62% |
| Dec 31, 2019 | 17.77% |
| Sep 30, 2019 | 9.06% |
| Jun 30, 2019 | 10.86% |
| Mar 31, 2019 | 13.13% |
| Dec 31, 2018 | 9.27% |
| Sep 30, 2018 | 8.34% |
| Jun 30, 2018 | 5.27% |
| Mar 31, 2018 | -4.90% |
| Dec 31, 2017 | 17.13% |
| Sep 30, 2017 | 22.03% |
| Jun 30, 2017 | -11.04% |
| Mar 31, 2017 | 9.70% |
| Dec 31, 2016 | 21.23% |
| Sep 30, 2016 | -18.70% |
| Jun 30, 2016 | -15.65% |
| Mar 31, 2016 | -71.53% |
| Dec 31, 2015 | 14.98% |
| Sep 30, 2015 | -7.67% |
| Jun 30, 2015 | -8.75% |
| Mar 31, 2015 | -13.16% |
| Dec 31, 2014 | -22.20% |
| Sep 30, 2014 | -17.50% |
| Jun 30, 2014 | -15.93% |